p53 facilitates pRb cleavage in IL-3-deprived cells: Novel pro-apoptotic activity of p53

EMBO Journal

Volumn 17, Issue 13, 1998, Pages 3587-3596

  Gottlieb, Eyal ^a   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Apoptosis; Caspase; Interleukin 3; p53; Retinoblastoma

Indexed keywords

INTERLEUKIN 3; PROTEIN P53; RETINOBLASTOMA PROTEIN;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; WART VIRUS;

APOPTOSIS; CELL LINE; HUMANS; INTERLEUKIN-3; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032127463     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.13.3587     Document Type: Article

References (84)

1. Abrahamson, J.L.A., Lee, J.M. and Bernstein, A. (1995) Regulation of P53-mediated apoptosis and cell cycle arrest by steel factor. Mol. Cell Biol., 15, 6953-6960.
2. Almasan, A., Yin, Y.X., Kelly, R.E., Lee, E.Y.H.P., Bradley, A., Li, W.W., Bertino, J.R. and Wahl, G.M. (1995) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes and apoptosis. Proc. Natl Acad. Sci. USA, 92, 5436-5440.
3. An, B. and Dou, Q.P. (1996) Cleavage of retinoblastoma protein during apoptosis: an interleukin-1 beta-converting enzyme-like protease as candidate. Cancer Res., 56, 438-442.
4. Attardi, L.D., Lowe, S.W., Brugarolas, J. and Jacks, T. (1996) Transcriptional activation by p53, but not induction of the P21 gene, is essential for oncogene-mediated apoptosis. EMBO J., 15, 3693-3701.
5. Bates, S. and Vousden, K.H. (1996) P53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6, 12-18.
6. Berry, D. E., Lu, Y.M., Schmidt, B., Fallon, P.G., Oconnell, C., Hu, S.X., Xu, H.J. and Blanck, G. (1996) Retinoblastoma protein inhibits IFN-gamma-induced apoptosis. Oncogene, 12, 1809-1819.
7. Blandino, G., Scardigli, R., Rizzo, M.G., Crescenzi, M., Soddu, S. and Sacchi, A. (1995) Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells. Oncogene, 10, 731-737.
8. Caelles, C., Helmberg, A. and Karin, M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
9. Canman, C.E., Gilmer, T.M., Coutts, S.B. and Kastan, M.B. (1995) Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9, 600-611.
10. Canman, C.E. and Kastan, M.B. (1997) Role of p53 in apoptosis. Adv. Pharmacol., 41, 429-460.
11. Chen, W.D., Otterson, G.A., Lipkowitz, S., Khleif, S.N., Coxon, A.B. and Kaye, F.J. (1997) Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene, 14, 1243-1248.
12. Clarke, A.R., Maandag, E.R., Vanroon, M., Vanderlugt, N.M.T., Vandervalk, M., Hooper, M.L., Berns, A. and Riele, H.T. (1992) Requirement for a functional Rb-1 gene in murine development. Nature, 359, 328-330.
13. Cobrinik, D. et al. (1996) Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev., 10, 1633-1644.
14. Cohen, G.M. (1997) Caspases: the executioners of apoptosis. Biochem. J., 326, 1-16.
15. Collins, M.K.L., Marvel, J., Malde, P. and Lopez-Rivas, A. (1992) Interleukin-3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med., 176, 1043-1051.
16. Davies, R., Hicks, R., Crook, T., Morris, J. and Vousden, K. (1993) Human Papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequence necessary for transformation. J. Virol., 67, 2521-2528.
17. Debbas, M. and White, E. (1993) Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7, 546-554.
18. Edmonds, C. and Vousden, K.H. (1989) A point mutational analysis of human Papillomavirus type 16 E7 protein. J. Virol., 63, 2650-2656.
19. Fan, G.S., Ma, X.M., Kren, B.T. and Steer, C.J. (1996) The retinoblastoma gene product inhibits TGF-beta 1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene, 12, 1909-1919.
20. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Livingston, D.M., Orkin, S.H. and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85, 549-561.
21. Fromm, L., Shawlot, W., Gunning, K., Butel, J.S. and Overbeek, P.A., (1994) The retinoblastoma protein-binding region of simian virus 40 large T antigen alters cell cycle regulation in lenses of transgenic mice. Mol. Cell Biol., 14, 6743-6754.
22. Gajewski, T.F. and Thompson, C.B. (1996) Apoptosis meets signal transduction: elimination of a BAD influence. Cell, 87, 589-592.
23. Gorospe, M., Cirielli, C., Wang, X.T., Seth, P., Capogrossi M.C. and Holbrook, N.J. (1997) p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene, 14, 929-935.
24. Gottlieb, E., Haffner, R., von-Ruden, T., Wagner, E.F. and Oren, M. (1994) Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J., 13, 1368-1374.
25. Gottlieb, E., Lindner, S. and Oren, M. (1996) Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells. Cell Growth Differ., 7, 301-310.
26. Gottlieb, T.M. and Oren, M. (1996) p53 in growth control and neoplasia. Biochim. Biophys. Acta - Rev. Cancer, 1287, 77-102.
27. Haas-Kogan, D.A., Kogan, S.C., Levi, D., Dazin, P., Tang, A., Fung, Y.K.T. and Israel, M.A. (1995) Inhibition of apoptosis by the retinoblastoma gene product. EMBO J., 14, 461-472.
28. Hansen, R. and Oren, M. (1997) p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev., 7, 46-51.
29. Hansen, R., Reddel, R. and Braithwaite, A. (1995) The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRb-mediated growth arrest or apoptosis. Oncogene, 11, 2535-2545.
30. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K.H. and Oren, M. (1995a) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev., 9, 2170-2183.
31. Haupt, Y., Rowan, S. and Oren, M. (1995b) p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene, 10, 1563-1571.
32. Herwig, S. and Strauss, M. (1997) The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem., 246, 581-601.
33. Hiebert, S.W., Packham, G., Strom, D.K., Haffner, R., Oren, M., Zambetti, G. and Cleveland, J.L. (1995) E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell Biol., 15, 6864-6874.
34. Howes, K.A., Ransom, L.N., Papermaster, D.S., Lasudry, J.G.H., Albert, D.M. and Windle, J.J. (1994) Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev., 8, 1300-1310.
35. Ihle, J.N. (1984) Biochemical and biological properties of interleukin-3: a lymphokine mediating the differentiation of lineage of cells that includes prothymocytes and mastlike cells. Contemp. Topic. Mol. Immunol., 10, 93-119.
36. Ishioka, C., Englert, C., Winge, P. Yan, Y.X., Engelstein, M. and Friend, S.H. (1995) Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene, 10, 1485-1492.
37. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A. and Weinberg, R.A. (1992) Effects of an Rb mutation in the mouse. Nature, 359, 295-300.
38. Janicke, R.U., Walker, P.A., Lin, X.Y. and Porter, A.G. (1996) Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J., 15, 6969-6978.
39. Karasuyama, H. and Melchers, F. (1988) Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol., 18, 97-104.
40. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev., 10, 1054-1072.
41. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
42. Lee, E.Y.H.P., Chang, C.Y., Hu, N.P., Wang, Y.C.J., Lai, C.C., Herrup, K., Lee, W.H. and Bradley, A. (1992) Mice deficient for Rb Are nonviable and show defects in neurogenesis and haematopoiesis. Nature, 359, 288-294.
43. Lee, M.H., Williams, B.O., Mulligan, G., Mukai, S., Bronson, R.T., Dyson, N., Harlow, E. and Jacks, T. (1996) Targeted disruption of p107: functional overlap between p107 and Rb. Genes Dev., 10, 1621-1632.
44. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
45. Lin, Y.P. and Benchimol, S. (1995) Cytokines inhibit p53-mediated apoptosis but not p53-mediated G (1) arrest. Mol. Cell Biol, 15, 6045-6054.
46. Lotem, J. and Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092-1096.
47. Lotem, J. and Sachs, L. (1997) Cytokine suppression of protease activation in wild-type p53-dependent and p53-independent apoptosis. Proc. Natl Acad. Sci. USA, 94, 9349-9353.
48. Macleod, K.F. Hu, Y.W. and Jacks, T. (1996) Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J., 15, 6178-6188.
49. McConkey, D.J., Goodrich, D., Bucana, C. and Klostergaard, J. (1996) The human retinoblastoma gene product suppresses ceramide-induced apoptosis in human bladder tumor cells. Oncogene, 13, 1693-1700.
50. Miller, D.K. (1997) The role of the caspase family of cysteine proteases in apoptosis. Semin. Immunol., 9, 35-49.
51. Morgenbesser, S.D., Williams, B.O., Jacks, T. and Depinho, R.A. (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature, 371, 72-74.
52. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acid Res., 18, 3587-3596.
53. Muller, A.J., Young, J.C., Pendergast, A.-M., Pondel, M., Landau, N.R., Littman, D.R. and Witte, O.N. (1991) BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of philadelphia chromosome-positive human leukemias. Mol. Cell Biol., 11, 1785-1792.
54. Ohta, T., Kinoshita, T., Naito, M. Nozaki, T., Masutani, M., Tsuruo, T. and Miyajima, A. (1997) Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J. Biol. Chem., 272, 23111-23116.
55. Pan, H. and Griep, A.E. (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev., 8, 1285-1299.
56. Pear, W.S., Nolan, G.P., Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
57. Poluha, W., Poluha, D.K., Chang, B.C., Crosbie, N.E., Schonhoff, C.M., Kilpatrick, D.L. and Ross, A.H. (1996) The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol. Cell Biol., 16, 1335-1341.
58. Polyak, K., Waldman, T., He, T.C., Kinzler, K.W. and Vogelstein, B. (1996) Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10, 1945-1952.
59. Polyak, K., Xia, Y., Zweier, J.L., Kinzler, K.W. and Vogelstein, B. (1997) A model for p53-induced apoptosis. Nature, 389, 300-305.
60. Qin, X.Q., Livingston, D.M., Kaelin, W.G. and Adams, P.D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA, 91, 10918-10922.
61. Reed, J.C. (1997) Double identity for proteins of the bcl-2 family. Nature, 387, 773-776.
62. Sabbatini, P., Lin, J.Y., Levine, A.J. and White, E. (1995) Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev., 9, 2184-2192.
63. Sabbatini, P., Han, J., Chiou, S.-K., Nicholson, D.W. and White, E. (1997) Interleukin-1b converting enzyme-like protease are essential for p53-mediated transcriptionally dependent apoptosis. Cell. Growth Diff., 8, 643-653.
64. Salvesen, G.S. and Dixit, V.M. (1997) Caspases: intracellular signaling by proteolysis. Cell, 91, 443-446.
65. Shan, B. and Lee, W.H. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol., 14, 8166-8173.
66. Shen, Y.Q. and Shenk, T. (1994) Relief of p53-mediated transcriptional repression by the adenovirus E1B 19 kDa protein or the cellular bcl-2 protein. Proc. Natl Acad. Sci. USA, 91, 8940-8944.
67. Slack, R.S., Skerjanc, I.S., Lach, B., Craig, J., Jardine, K. and McBurney, M.W. (1995) Cells differentiating into neuroectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins. J. Cell Biol., 129, 779-788.
68. Tan, X. and Wang, J.Y. (1998) The caspase-RB connection in cell death. Trends Cell Biol., 8, 116-120.
69. Tan, X.Q., Martin, S.J., Green, D.R. and Wang, J.Y.J. (1997) Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J. Biol. Chem., 272, 9613-9616.
70. Wagner, A.J., Kokontis, J.M. and Hay, N. (1994) Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 (waf1/cip1). Genes Dev., 8, 2817-2830.
71. Wang, H.G., Rapp, U.R. and Reed, J.C. (1996) Bcl-2 targets the protein kinase raf-1 to mitochondria. Cell, 87, 629-638.
72. Wang, J., Guo, K., Wills, K.N. and Walsh, K. (1997) Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res., 57, 351-354.
73. Wang, J. and Walsh, K. (1996) Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science, 273, 359-361.
74. Wang, J.Y.J. (1997) Retinoblastoma protein in growth suppression and death protection. Curr. Opin. Genet. Dev., 7, 39-45.
75. Whitaker, L.L. and Hansen, M.F. (1997) Induction of apoptosis in Mv1Lu cells by expression of competitive RB1 mutants. Oncogene, 15, 1069-1077.
76. White, E. (1994) p53, guardian of Rb. Nature, 371, 21-22.
77. Wu, X.W. and Levine, A.J. (1994) P53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl Acad. Sci. USA., 91, 3602-3606.
78. Wyllie, A. (1997) Apoptosis - clues in the p53 murder mystery. Nature, 389, 237-238.
79. Xiao, Z.X., Chen, J.D., Levine, A.J., Modjtahedi, N., Xing, J., Sellers, W.R. and Livingston, D.M. (1995) Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature, 375, 694-698.
80. Yamasaki, L., Jacks, T., Bronson, R., Goillot, E., Harlow, E. and Dyson, N.J. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85, 537-548.
81. Yonish-Rouach, E., Deguin, V., Zaitchouk, T., Breugnot, C., Mishal, Z., Jenkins, J.R. and May, E. (1995) Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene, 11, 2197-2205.
82. Zacksenhaus, E., Jiang, Z., Chung, D., Marth, J.D., Phillips, R.A. and Gallie, B.L. (1996) pRb controls proliferation differentiation and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev., 10, 3051-3064.
83. Zha, J.P., Harada, H., Yang, E., Jockel, J. and Korsmeyer, S.J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L). Cell, 87, 619-628.
84. Zhu, Y.M., Bradbury, D.A. and Russell, N.H. (1994) Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br. J. Cancer, 69, 468-472.